The Venture Codex Logo

The Venture Codex

PharmEasy

1st Floor, Ashok Silk Mills Compound, E Shape Building, Lal Bahadur Shastri Marg, opposite Damodar Park, Ghatkopar West, Mumbai, Maharashtra, 400086, India

Overview

PharmEasy is a health tech startup offering services such as teleconsultation, medicine deliveries, and diagnostic test sample collections. It also operates an online pharmacy that helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. The startup company is funded and backed by Caisse de Dépôt et Placement du Québec (CDPQ), Ascent Health, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, InnoVen Capital, and Temasek Holdings. PharmEasy was founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health.

Total investments
1
Lead investments
0
Investments · 12mo
0
Active investors
8

Sector focus

  • E-Commerce
  • Health Care
  • Health Diagnostics
  • Pharmaceutical
  • Wellness
Visit website

Investment portfolio

  • BeatO

    Participated · Equity · Jul 2021

    BeatO is an Indian diabetes care provider. The company's core focus is on diabetes care. It has raised $33 million in a Series B funding round. The round was led by Lightrock India and included participation from HealthQuad, Flipkart Ventures and existing investors. The fundraising was announced on Wednesday. The article did not provide operating metrics or details on use of proceeds. BeatO provides a digital care ecosystem combining IoT‑connected devices and an app to enable real‑time monitoring, AI‑driven personalized insights, and proactive intervention by doctors and health coaches for patients with chronic conditions. The platform focuses on cardiometabolic conditions and aims to expand care across channels and geographies. The company recently launched operations in Singapore as part of its ASEAN expansion. BeatO is led by co‑founder and CEO Gautam Chopra. Financially, the company has raised more than USD 10m over the last year and completed an additional USD 5.7M funding round. BeatO plans to use the new funds to grow its subscriber base and enhance product capabilities to cover more cardiometabolic conditions. BeatO offers a smartphone-based glucometer that connects to a mobile app which stores readings and links users with doctors and diabetes educators for real-time guidance and alerts to family and caregivers. The company targets end-to-end needs of people with diabetes and sells its glucometer directly to consumers. BeatO plans to use new funds to increase its user base and revenue and to expand its product line for its flagship glucometer and FMCG/retail categories. The company reported that its user base and revenue have grown tenfold over the past 12 months. BeatO was founded in 2015 by Gautam Chopra and Yash Sehgal and is based in Delhi. It currently claims to serve 50,000 diabetic customers across more than 1,500 cities. BeatO is a full-stack platform for people living with diabetes that offers a mobile-based monitoring solution, a smartphone-based glucometer, and diabetes-specific products such as diabetic snacks, specialty food, and footwear. Founded in 2015 by Yash Sehgal and Abhishek Kumar Gautam Chopra and based in Delhi, the startup serves 25,000 active customers across more than 1,500 cities. The company reports facilitating more than 250,000 glucose readings and an over 80% repeat order rate among acquired customers. BeatO says it grew revenue 10X within the last year. The startup plans to use new proceeds to add products across categories useful for diabetics and to leverage technology to make them more accessible. Previous financing includes an angel round from individual investors such as Rajeev Chitrabhanu and Vishal Sampat.

Team